Flash 7 is required to view this content. Download Flash 7.
Advancing Life Science Together ®
As scientists and engineers pioneering new cures to mankind's most challenging health issues, you rely on Millipore as a trusted partner who for more than 50 years has supported you with a continuum of cutting edge tools, technologies and application solutions to ensure success in your research, development and production.
Specialty Markets
Diagnostics & OEM, Vaccines, Beverage, Drinking Water and Wastewater, Hospital Pharmacy, and Microelectronics.
Media Room
Millipore Corporation Announces Convertibility of 3.75% Convertible Senior Notes Due 2026
Millipore Corporation today announced that its shareholders voted at a Special Meeting of Shareholders to approve the previously-announced acquisition of all outstanding shares of common stock of Millipore by Merck KGaA of Germany, the global pharmaceutical and chemical company.
Important Information for Bondholders:
July 15, 2010: Millipore Corporation Announces Effective Date of Make-Whole Fundamental Change and Increase in Conversion Rate due to Make-Whole Fundamental Change Relating to its 3.75% Convertible Senior Notes Due 2026.
Scepter Handheld Automated Cell Counter
June 29, 2010: Biocompare Product Review:...."Much of our research of late has involved cell-based assays such as ADCC (antibody-dependent, cell-mediated cytotoxicity) and migration... We are always on the lookout for automated cell counters that eliminate the need for tedious and inaccurate manual counting methods."
Quick Purchase
My Favorites
Track Order
Previous Orders
Create an Online Account
RSS Feeds
Careers
Investor Services
Millipore Support
Customer Service
Worldwide Offices
Suggestions & Feedback